Welcome to your Daily Dose of Health Tech Innovation!
Stay ahead with the latest breakthroughs revolutionizing healthcare—from AI diagnostics to remote care solutions.
We bring you expert-curated insights, emerging trends, and must-know updates from the digital health frontier.
Whether you’re a clinician, innovator, or health tech enthusiast, this roundup delivers what matters most.
Let’s dive into the future of health, one innovation at a time.
Swoop Appoints Sara Michael as EVP of Content at MyHealthTeam
Swoop, a leader in AI-driven, data-powered, and privacy-compliant omnichannel healthcare marketing, announced the appointment of Sara Michael as Executive Vice President of Content at MyHealthTeam, reinforcing the company’s commitment to delivering trusted, medically verified information and meaningful engagement for people living with chronic and rare conditions.
Gold Coast Health Plan Appoints Acting Chief Medical Officer to Permanent Role
Gold Coast Health Plan announced the appointment of Dr. James Cruz as its new chief medical officer (CMO), effective immediately.
Vicebio, Next-generation Vaccine Biotech, To Be Acquired By Sanofi For US $1.6 Billion
Vicebio Ltd, a biopharmaceutical company developing novel vaccines against life-threatening respiratory viral infections, has entered an exclusive, definitive agreement to be acquired by Sanofi. Under the terms of the agreement, subject to customary conditions, Vicebio shareholders will receive up to a total of US$1.6 billion, including an upfront payment of US$1.15 billion as well as development and regulatory milestones payments of US$450 million.
Danaher Announces Transition Plan for Chief Financial Officer
Danaher Corporation, a leading global life sciences and diagnostics innovator, announced that Matthew Gugino, currently Group Chief Financial Officer of the Company’s Life Sciences Innovations Group and Vice President of Financial Planning & Analysis, will succeed Matthew McGrew as Danaher’s Chief Financial Officer effective February 28th, 2026. Following the transition and consistent with past practice, Mr. McGrew will continue thereafter as an Executive Vice President of the Company, as he begins a gradual transition to retirement, after more than 20 years with Danaher.
Medunik USA Expands Siklos Coverage Under Medicaid Programs To 37 States
Medunik USA, a specialty pharmaceutical company dedicated to providing rare disease patients with access to orphan drugs and part of Duchesnay Pharmaceutical Group (DPG), winner of the 2024 Life Sciences Innovation Award by ADRIQ, is pleased to announce that public reimbursement for Siklos (hydroxyurea) under Medicaid Programs is now available in 37 states, with 13 states including it on their Preferred Drug List, while 24 states offer it with limited, or no, restrictions. This important milestone for Medunik USA allows broader access to this essential medicine, benefiting patients suffering from sickle cell disease (SCD).
To share your insights, please write to us at sudipto@intentamplify.com
